Share on LinkedInShare on LinkedIn

ARTICLE · 01 SEPTEMBER 2023

US Court Rules That Free Samples Don't Count Towards Commercial Success

A product's commercial success in the marketplace can be used to prove the inventiveness of a patent, but a US court warns that free samples are not relevant.

GlobalIntellectual Property

Incept LLC v. Palette Life Sciences Inc. et al., 2021-2063, 2021-2065 (Fed. Cir. Aug 16, 2023)

A product's commercial success in the marketplace can be used to prove the inventiveness of a patent, but a US court warns that free samples are not relevant. Affirming written decisions of the Patent Trial and Appeal Board ("PTAB") in two inter partes reviews, the Court of Appeals for the Federal Circuit ("CAFC") ruled that only actual product sales count towards supporting commercial success. The CAFC also clarified that a general preference for an alternative in the prior art does not teach way from the invention, and dependent claims will automatically fall with an independent claim when they are not argued separately.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from